Syndax Pharmaceuticals Inc (NASDAQ:SNDX) price on Thursday, May 01, fall -2.33% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $13.82.
A look at the stock’s price movement, the close in the last trading session was $14.15, moving within a range at $13.675 and $14.195. The beta value (5-Year monthly) was 1.282. Turning to its 52-week performance, $25.07 and $9.66 were the 52-week high and 52-week low respectively. Overall, SNDX moved 15.07% over the past month.
Syndax Pharmaceuticals Inc’s market cap currently stands at around $1.19 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-02.
Turning to the stock’s technical picture we see that short term indicators suggest on average that SNDX is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 4 recommend SNDX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
SNDX’s current price about 13.65% and 4.60% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 59.88, while 7-day volatility ratio is 5.08% and 8.38% in the 30-day chart. Further, Syndax Pharmaceuticals Inc (SNDX) has a beta value of 0.82, and an average true range (ATR) of 0.85. Analysts have given the company’s stock an average 52-week price target of $18, forecast between a low of $18 and high of $18. Looking at the price targets, the low is -30.25% off current price level while to achieve the yearly target high, price needs to move -30.25%. Nonetheless, investors will most likely welcome a -30.25% jump to $18 which is the analysts’ median price.
If we refocus on Syndax Pharmaceuticals Inc (NASDAQ:SNDX), historical trading data shows that trading volumes averaged 1.62 over the past 10 days and 2.06 million over the past 3 months. The company’s latest data on shares outstanding shows there are 85.69 million shares.
The 2.17% of Syndax Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 111.90% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 21.17 million on 2025-04-15, giving us a short ratio of 11.32. The data shows that as of 2025-04-15 short interest in Syndax Pharmaceuticals Inc (SNDX) stood at 2779.0 of shares outstanding, with shares short rising to 18.82 million registered in 2025-03-14. Current price change has pushed the stock 4.54% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the SNDX stock continues to rise going into the next quarter.
